SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
AURA

Aura Biosciences, Inc. (NASDAQ:AURA)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$6.87-$0.11 (-1.58%)
 
Market cap
$715M
Insider Score
Health Score
Analyst consensus
Listed since
Oct 29, 2021
Market Cap$714.99M+24.9%
Revenue (ttm)$0
Net Income-$136.95M-28.6%
EPS-$1.67+13.9%
Shares Out104.07M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume791,134
Open$6.81
Previous Close$6.98
Day's Range$6.79 - $6.98
52-Week Range$4.73 - $9.54
Beta0.44
AnalystsBuy
Price Target$16.50(+140.17%)
Earnings DateMar 29, 2027

About AURA

Headquartered in Cambridge, Massachusetts, Aura Biosciences, Inc. is a biotechnology firm established in 2009 that specializes in pioneering cancer treatments. The company leverages its proprietary virus-like drug conjugate (VDC) technology platform to address tumors with significant unmet medical needs, specifically in ocular (eye) and urologic oncology. Its flagship therapeutic candidate, AU-011, is a VDC currently in development for the treatment of primary choroidal melanoma. Furthermore, Aura Biosciences is investigating AU-011's potential for other ocular oncology applications, such as choroidal metastases.

Address
85 Bolton Street, Boston, MA, 02135, US
Market Cap
715 million
Employees
113
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$39.80M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Fair
From AURA’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
-1.58%
5 Days
-2.55%
1 Month
+6.35%
6 Months
-9.61%
1 Year
+24.91%

$AURA stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in AURA holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by AURA's directors and management

Net Shares Purchased by Insiders−7M−3.5M02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

AURA Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New AURA patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to AURA from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in AURA

VTIVanguard Morningstar Total Stock Market ETF$13.54M
IWMiShares Russell 2000 ETF$10.64M
XBIState Street SPDR S&P Biotech ETF$6.71M
VXFVanguard Extended Market ETF$6.61M
IWOiShares Russell 2000 Growth ETF$3.54M
IBBiShares Biotechnology ETF$3.54M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from AURA’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
99
News & Sentiment
20% of score
72

News check: Partnership expansion for lead oncology program, analyst upgrades citing growth potential, and Q3 results reporting support bullish outlook with concrete business developments.

Recent Insider Activity

Buys
0
Sells
8
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

BBCVirtus Biotech Clinical Trials ETF0.88%
EVNTAltShares Event-Driven ETF0.61%
WCEOHypatia Women CEO ETF0.22%
IWCiShares Micro-Cap ETF0.11%
FSEGFidelity Enhanced Small Cap Growth ETF0.08%
XBIState Street SPDR S&P Biotech ETF0.07%
IBBQInvesco Nasdaq Biotechnology ETF0.05%
FESMFidelity Enhanced Small Cap ETF0.04%
IBBiShares Biotechnology ETF0.03%
BIBProShares Ultra Nasdaq Biotechnology0.03%
FSEVFidelity Enhanced Small Cap Value ETF0.02%
PWSPacer WealthShield ETF0.01%

Weight is the stock’s share of each fund’s holdings.